AVEO Pharmaceuticals Competitors and Similar CompaniesClear all

AVEO Pharmaceuticals's competitors and similar companies include Moleculin Biotech, Immodulon Therapeutics and Khloris Biosciences.

	AVEO Pharmaceuticals AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics.	Moleculin Biotech Moleculin Biotech is a pharmaceutical company focused on the development of anti-cancer drug candidates.	Immodulon Therapeutics Immodulon Therapeutics is an immuno-oncology company focused on the development of treatments for cancer.	Khloris Biosciences Khloris Biosciences is a biotechnology company developing the treatment of cardiovascular, oncology, and other diseases.
Founding Date	Founding Date 2001	Founding Date 2006	Founding Date N/A	Founding Date 2017
Type	Type Public	Type Public	Type Private	Type Private
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Boston, US HQ	Locations Houston, US HQ	Locations Hayes, GB HQ London, GB	Locations Mountain View, US HQ
Employees	Employees 1912% increase	Employees 176% decrease	Employees 10	Employees 1214% decrease
Valuation ($)	Valuation ($) 515.6 m	Valuation ($) 7.5 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Net income	Net income ($53.3m) (FY, 2021)	Net income ($33.6m) (FY, 2025)	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised $ 224m	Total funding raised $ 491k	Total funding raised N/A	Total funding raised $ 5m